Design Therapeutics, Inc. [DSGN]

Source: 

Company Overview

Design Therapeutics, Inc. is a biopharmaceutical company pioneering the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.